Skip to content
Shameless Cloning

Search Shameless Cloning

Search superinvestors, stocks, insiders and members of Congress

Q2 2026 13F · SEC CIK 1389574

Nicholas Investment Partners, LP

Investment managerFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗

Reported 13F value
$1.6B
Reported positions
175
Top holdings a year, 3 yrs
+28.1%
Average holding period
1.5 yrs

Nicholas Investment Partners, LP is an investment manager that reported 175 positions worth $1.6B in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Bwx Technologies Inc (BWXT, 3.4%), Revolution Medicines Inc (RVMD, 3.0%), Callaway Golf Co (MODG, 2.4%). A portfolio copying its top holdings returned 28.1% a year over the last 3 years, against 20.4% for the S&P 500.

Nicholas Investment Partners, LP holdings largest 50 of 175 positions.

Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.

Nicholas Investment Partners, LP 13F holdings
Stock% of 13F valueShare changeReported value
BWXTBwx Technologies Inc3.4%+4.0%$53.0M
RVMDRevolution Medicines Inc3.0%-6.3%$45.8M
MODGCallaway Golf Co2.4%+73.6%$36.7M
MODModine Mfg Co1.9%+4.8%$29.7M
CRSCarpenter Technology Corp1.7%+4.5%$26.9M
LINCLincoln Edl Svcs Corp1.7%+15.8%$26.5M
NVDANvidia Corporation Com1.6%+7.0%$25.3M
STRLSterling Infrastructure Inc1.6%-39.4%$25.3M
AXSMAxsome Therapeutics Inc.1.6%+21.5%$24.2M
GEVGe Vernova Inc1.6%-32.5%$24.1M
XENEXenon Pharmaceuticals Inc1.5%+60.2%$23.9M
BBIOBridgebio Pharma Inc1.5%+4.2%$23.2M
LSCCLattice Semiconductor Corp1.4%+4.0%$22.4M
KTBKontoor Brands Inc Com1.4%—$21.8M
TSMTaiwan Semiconductor Manufac1.4%+9.4%$21.5M
WTFCWintrust Financial Corp1.4%+11.5%$20.9M
SITMSitime Corp1.3%+2.9%$20.5M
TFIITfi International Inc1.3%+5.7%$20.3M
MIRMMirum Pharmaceuticals Inc1.3%+31.5%$20.2M
ELVNEnliven Therapeutics Inc1.3%—$19.9M
AVGOBroadcom Inc1.3%+0.0%$19.8M
SPHRSphere Entertainment Co1.3%+5.2%$19.8M
DNTHDianthus Therapeutics Inc1.2%—$18.2M
AMZNAmazon Com Inc Com1.2%+6.7%$17.9M
CYTKCytokinetics Inc1.1%—$17.8M
CCJCameco Corp Com1.1%+0.3%$17.7M
AEISAdvanced Energy Inds1.1%+13.2%$17.0M
SKTTanger Inc1.1%+5.2%$17.0M
RSIRush Street Interactive Inc1.1%+4.0%$16.8M
MPWRMonolithic Power Systms Inc1.1%+0.8%$16.8M
KLACKla Corp1.1%—$16.7M
POWLPowell Industries Inc1.1%+215.6%$16.7M
OFRMOnce Upon A Farm Pbc1.0%—$16.1M
RYTMRhythm Pharmaceuticals Inc1.0%—$15.5M
FTAIFtai Aviation Ltd1.0%-10.1%$15.2M
ROIVRoivant Sciences Ltd1.0%—$14.8M
XOMExxon Mobil Corp0.9%+0.0%$14.4M
LTHLife Time Group Holdings Inc0.9%—$14.2M
PARRPar Pac Holdings Inc0.9%-0.1%$14.1M
MTSIMacom Tech Solutions Hldgs I0.9%-27.1%$13.7M
SMTCSemtech Corp0.9%—$13.7M
GSGoldman Sachs Group Inc0.8%+0.0%$13.1M
XPOXpo Inc0.8%-0.2%$13.1M
HAPNLendingclub Corp0.8%—$12.9M
SHOOMadden Steven Ltd0.8%—$12.2M
PLPlanet Labs Pbc0.8%+5.2%$11.8M
ATROAstronics Corp0.8%—$11.7M
ONTOOnto Innovation Inc0.7%—$11.3M
AGXArgan, Inc.0.7%—$11.3M
GOOGAlphabet Inc0.7%—$11.0M

What Nicholas Investment Partners, LP bought and sold in Q2 2026, against Q1 2026.

Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.

How the holdings did against the S&P 500.

1 year
+22.8% /yr
S&P 500 +20.1%
3 years
+28.1% /yr
S&P 500 +20.4%
5 years
+12.1% /yr
S&P 500 +11.6%

A portfolio of the filer's 20 largest 13F positions, weighted by value and rebuilt each quarter on the day the filing became public. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.

Reported 13F value by quarter.

13F value by quarter
Quarter13F valuePositions
Q2 2026$1.6B175
Q1 2026$1.2B178
Q4 2025$1.2B177
Q3 2025$1.1B181
Q2 2025$999.7M183
Q1 2025$863.4M166
Q4 2024$1.0B183
Q3 2024$978.9M184
Q2 2024$859.9M157
Q1 2024$886.1M168
Q4 2023$775.0M163
Q3 2023$1.3B150

Questions about Nicholas Investment Partners, LP's portfolio

What stocks does Nicholas Investment Partners, LP own?

Nicholas Investment Partners, LP's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 175 positions worth $1.6B. The largest are Bwx Technologies Inc (BWXT) at 3.4%, Revolution Medicines Inc (RVMD) at 3.0%, Callaway Golf Co (MODG) at 2.4%, Modine Mfg Co (MOD) at 1.9% and Carpenter Technology Corp (CRS) at 1.7%.

What did Nicholas Investment Partners, LP buy last quarter?

In Q2 2026, Nicholas Investment Partners, LP added Powell Industries Inc (POWL) (+215.6% shares), Callaway Golf Co (MODG) (+73.6% shares) and Xenon Pharmaceuticals Inc (XENE) (+60.2% shares), compared with its Q1 2026 filing.

What did Nicholas Investment Partners, LP sell last quarter?

In Q2 2026, Nicholas Investment Partners, LP cut from its top 50 Insmed Inc (INSM), cut from its top 50 Kratos Defense & Sec Solutio (KTOS), cut from its top 50 Embraer S.a. (EMBJ), cut from its top 50 Century Alum Co (CENX), cut from its top 50 Nuvalent Inc (NUVL), Sterling Infrastructure Inc (STRL) (-39.4% shares), Ge Vernova Inc (GEV) (-32.5% shares) and Macom Tech Solutions Hldgs I (MTSI) (-27.1% shares), compared with its Q1 2026 filing.

How has Nicholas Investment Partners, LP's portfolio performed?

A portfolio copying Nicholas Investment Partners, LP's 20 largest 13F holdings each quarter, from the day each filing was public, returned +28.1% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +22.8% against +20.1%. Over 5 years: +12.1% a year against +11.6%.

When is Nicholas Investment Partners, LP's next 13F filing due?

13F filings are due 45 days after each quarter ends. Nicholas Investment Partners, LP's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.